These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7788144)
1. Bcl-2 expression is unaltered in unfractionated peripheral blood mononuclear cells in patients with systemic lupus erythematosus. Rose LM; Latchman DS; Isenberg DA Br J Rheumatol; 1995 Apr; 34(4):316-20. PubMed ID: 7788144 [TBL] [Abstract][Full Text] [Related]
2. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Lorenz HM; Grünke M; Hieronymus T; Herrmann M; Kühnel A; Manger B; Kalden JR Arthritis Rheum; 1997 Feb; 40(2):306-17. PubMed ID: 9041943 [TBL] [Abstract][Full Text] [Related]
3. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Aringer M; Wintersberger W; Steiner CW; Kiener H; Presterl E; Jaeger U; Smolen JS; Graninger WB Arthritis Rheum; 1994 Oct; 37(10):1423-30. PubMed ID: 7945466 [TBL] [Abstract][Full Text] [Related]
4. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus. Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810 [TBL] [Abstract][Full Text] [Related]
5. Bcl-2 and Fas, molecules which influence apoptosis. A possible role in systemic lupus erythematosus? Rose LM; Latchman DS; Isenberg DA Autoimmunity; 1994; 17(4):271-8. PubMed ID: 7524704 [TBL] [Abstract][Full Text] [Related]
6. Increased rate of apoptosis and decreased expression of bcl-2 protein in peripheral blood lymphocytes from patients with active systemic lupus erythematosus. Chan EY; Ko SC; Lau CS Asian Pac J Allergy Immunol; 1997 Mar; 15(1):3-7. PubMed ID: 9251841 [TBL] [Abstract][Full Text] [Related]
7. Reduced expressions of Fas and Bcl-2 proteins in CD14+ monocytes and normal CD14 soluble levels in juvenile systemic lupus erythematosus. Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C Lupus; 2013 Aug; 22(9):940-7. PubMed ID: 23846229 [TBL] [Abstract][Full Text] [Related]
8. Bcl-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemic lupus erythematosus disease activity. Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M Anticancer Res; 1999; 19(4B):3073-6. PubMed ID: 10652595 [TBL] [Abstract][Full Text] [Related]
9. Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Ohsako S; Hara M; Harigai M; Fukasawa C; Kashiwazaki S Clin Immunol Immunopathol; 1994 Oct; 73(1):109-14. PubMed ID: 7523011 [TBL] [Abstract][Full Text] [Related]
10. Differential oncogene and TNF-alpha mRNA expression in bone marrow cells from systemic lupus erythematosus patients. Alvarado-de la Barrera C; Alcocer-Varela J; Richaud-Patin Y; Alarcón-Segovia D; Llorente L Scand J Immunol; 1998 Nov; 48(5):551-6. PubMed ID: 9822266 [TBL] [Abstract][Full Text] [Related]
11. The bcl-2 proto-oncogene is overexpressed in systemic lupus erythematosus. Gatenby PA; Irvine M J Autoimmun; 1994 Oct; 7(5):623-31. PubMed ID: 7840854 [TBL] [Abstract][Full Text] [Related]
12. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus. Seki M; Ushiyama C; Seta N; Abe K; Fukazawa T; Asakawa J; Takasaki Y; Hashimoto H Arthritis Rheum; 1998 May; 41(5):823-30. PubMed ID: 9588733 [TBL] [Abstract][Full Text] [Related]
13. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis. Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369 [TBL] [Abstract][Full Text] [Related]
14. Transcriptional overexpression of the proto-oncogene bcl-2 in patients with systemic Lupus erythematosus. Graninger WB Wien Klin Wochenschr; 1992; 104(7):205-7. PubMed ID: 1523845 [TBL] [Abstract][Full Text] [Related]
15. Increased Fas and Bcl-2 expression on peripheral mononuclear cells from patients with active juvenile-onset systemic lupus erythematosus. Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C J Rheumatol; 2007 Jul; 34(7):1580-4. PubMed ID: 17516614 [TBL] [Abstract][Full Text] [Related]
16. [Clinical significance and expression of Bcl-2 protein in patients with systemic lupus erythematosus]. Liu Y; Yin P; Zhao X; Shi C; Kong Q; Guan W Zhonghua Nei Ke Za Zhi; 1999 Feb; 38(2):94-7. PubMed ID: 11798633 [TBL] [Abstract][Full Text] [Related]
17. Increased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy. Hilliard BA; Zizzo G; Ulas M; Linan MK; Schreiter J; Cohen PL Arthritis Res Ther; 2014 Mar; 16(2):R76. PubMed ID: 24650765 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the BCL-2 gene locus as a susceptibility locus linked to the clinical expression of systemic lupus erythematosus (SLE). Huang QR; Morris D; Manolios N Rheumatol Int; 1996; 16(3):121-4. PubMed ID: 8893377 [TBL] [Abstract][Full Text] [Related]
19. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis. Du Y; Wu X; Chen M; Wang W; Xv W; Ye L; Wu D; Xue J; Sun W; Luo J; Wu H Clin Exp Immunol; 2017 May; 188(2):234-242. PubMed ID: 28063160 [TBL] [Abstract][Full Text] [Related]
20. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics. Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]